EMD 121974 in Treating Patients With Locally Advanced or Metastatic Cancer

ABSTRACT: RATIONALE: EMD 121974 may stop the growth of cancer by stopping blood flow to the tumor. PURPOSE: Phase I trial to study the effectiveness of EMD 121974 in treating patients who have locally advanced or metastatic cancer.

DISEASE(S): Myelodysplastic Syndromes,Extramedullary Plasmacytoma,Myeloproliferative Disorders,Leukemia,Preleukemia,Multiple Myeloma And Plasma Cell Neoplasm,Small Intestine Cancer,Angioimmunoblastic T-cell Lymphoma,Lymphoma,Monoclonal Gammopathy Of Undetermined Significance,Unspecified Adult Solid Tumor, Protocol Specific,Plasmacytoma,Precancerous Conditions,Intestinal Neoplasms,Precancerous/nonmalignant Condition,Neoplasms, Plasma Cell,Multiple Myeloma,Chronic Myeloproliferative Disorders

PROVIDER: 2003668 | ecrin-mdr-crc |

REPOSITORIES: ECRIN MDR